NEW POSITIVE ACTION STRATEGY & FUNDING

Strategy & Funding Themes

The ViiV Healthcare Positive Action strategy 2020- 2030 was launched in December 2019. Click here to download our high-level strategy. The strategy works towards achieving healthy communities in a world free of AIDS and supports ViiV’s mission of leaving no person living with HIV behind.

Positive Action has developed a logic framework which demonstrates how we will achieve our overall strategy.

Information for grantees who have received funding under the previous programmes (PACF, PAGW, PA, PA MSM&T and PA Europe can be found here).

The new Positive Action strategy has three categories of funding. Challenges, Community Strategic Initiatives and Breakthrough. 

For any questions relating to the Positive Action strategy 2020 - 2030 or the funding rounds please send an email to WW.PositiveAction@viivhealthcare.com

COVID19 -  Community Emergency Response Fund

ViiV Healthcare’s COVID19 Community Emergency Response Fund seeks applications from community-based organisations to support their work in addressing the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic. Requests for proposals will be open from 27 April 2020 through 15 May 2020 and is open to existing grantees of ViiV Healthcare’s Positive Action and/or Government Affairs and Global Public Health.

Community-based organisations will be supported with individual grants of up to £20,000 over a six-month period (more information here).

Community Emergency Response Fund

ViiV Healthcare’s COVID19 Community Emergency Response Fund seeks applications from community-based organisations to support their work in addressing the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic. Requests for proposals will be open from 27 April 2020 through 15 May 2020 and is open to existing grantees of ViiV Healthcare’s Positive Action and/or Government Affairs and Global Public Health.

Community-based organisations will be supported with individual grants of up to £20,000 over a six-month period.

Areas of Focus:

We invite proposals in one of the following thematic areas:

  • Support for ongoing access to critical HIV prevention, care and treatment services (adherence support interventions, psychosocial support, strengthening access to ARVs, strategies for hard to reach populations, etc.)
  • Capacity building to support the transition of service delivery from face to face service delivery to home or digital services etc.
  • Short term payments for critical community staff who are responding to COVID19 challenges (salaries, airtime, data, transport costs etc.)
  • Community monitoring and community feedback mechanisms on impact of COVID19 HIV services and support.

Application Process

All applications must be submitted by email to COVID19.Community@viivhealthcare.com.

Below are proposal materials as well as additional information:

  1. Guidance Notes (here
  2. FAQs (here)
  3. Application Form (here)
  4. Budget template (here)

The proposals will be reviewed by an internal ViiV Healthcare panel and successful applicants notified by 27 May 2020

 

Challenges

Positive Action Challenges seek to find innovative solutions to a particular issue or challenge.

Our most recent Challenge, focussing on Harm Reduction, run in partnership with IAS and INPUD, is now closed for applications. 

We plan to announce the recipients of the awards at AIDS 2020: Virtual.

Challenge question:

Can you design or scale up a community or peer-led initiative or programme that aims to provide comprehensive, innovative and accessible harm reduction services at the community level for people who inject drugs? If the answer is yes, check the following inclusion criteria.

Successful new ideas or existing projects needed to meet the following criteria:

  • Be community or peer-led.
  • Meaningfully engage and involve the community of people who inject drugs in the design and delivery of their initiative.
  • Promote non-stigmatising, inclusive and comprehensive care for people who use drugs.
  • Describe how harm reduction services can be integrated into existing community or local public health HIV support services and/or how HIV services can be integrated into harm reduction services.
  • Be able to demonstrate how the initiative drives increased and sustained access to HIV services and support through addressing current barriers e.g. outlining how existing policy, regulatory and programmatic barriers have been addressed to enhance accessibility and quality.

 Impact Photography/Shutterstock.com

  • Demonstrate how the project can be sustained beyond the award.

The Review Panel

Co-sponsors 

Other members of the review panel

Syda Productions/Shutterstock.com

Syda Productions/Shutterstock.com

HIV infections among people who inject drugs are rising. People who inject drugs and their sexual partners accounted for around one fifth of all people newly infected with HIV (outside of sub-Saharan Africa) in 2018. In two regions of the world—eastern Europe and central Asia and the Middle East and North Africa—people who inject drugs accounted for more than one third of new infections in 2018. Viral hepatitis and tuberculosis rates among people who use drugs are also high in many parts of the world. These preventable and treatable diseases, combined with overdose deaths, which are also preventable, are claiming hundreds of thousands of lives each year. In many countries across the globe, injecting drug use is not often acknowledged, and a public health response therefore not implemented.

Harm reduction is rooted in a commitment to addressing discrimination and ensuring that nobody is excluded from the health and social services they may need because of their drug use, their race, their gender, their gender identity, their sexual orientation, their choice of work, or their economic status. The meaningful involvement of people who use drugs in designing, implementing and evaluating programmes and policies that serve them is central to harm reduction.

Comprehensive harm reduction services — including needle–syringe programmes, opioid substitution therapy, drug dependence treatment, overdose prevention and testing and treatment for HIV, tuberculosis and hepatitis B and C— reduce the incidence of blood-borne infections, overdose deaths and other harms.

Community Strategic Initiatives

Positive Action Community Strategic Initiative has two type of grants. These are defined as follows: 

Innovator grants: £30 000 - £50 000 per year over two years. These grants are focussed on funding novel or innovative interventions at the community level.
Momentum grants: £50 000 - £100 000 per year over three years. These grants are focussed on advancing existing, evidence-based interventions to enable sustainable scale up. 

Funding Round 1: Innovator Grants - Opens 7 June 2020 at 00h01 BST and closes on 19 July 2020 at 23h59 BST
Theme: HIV-related Stigma focussing on two components. 

  • HIV self-stigma (global call).
  • Addressing HIV-related stigma in the Middle East and North Africa (limited to countries in MENA).

Click here to download a more detailed guidance note for these themes.

Funding Round 2: Momentum grants - Opens  6 September 2020 at 00h01 BST closes 18 October 2020 23h59 BST.

Theme: Addressing HIV in teenage mothers and their children. 

Geographic scope: Botswana, Cameroon, Eswatini, Kenya, Lesotho, Malawi, Mozambique, Namibia, South Africa, Tanzania, Uganda, Zambia and Zimbabwe.

More information will be published at the beginning of June.

Breakthrough

Breakthrough grants focus on strategic partnerships aimed at achieving targeted and strategic impact in order to achieve HIV targets more effectively and efficiently. The two thematic areas for 2020 – 2023 is focusing on ending paediatric AIDS by 2025 and ending AIDS amongst people who use drugs.    

Breakthrough grants are only available by invitation.